Northern Trust’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Northern Trust’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-270,149	Closed	-$5.65M	–	4261
2016 Q3	$5.65M	Sell	270,149 -25,076	-8%	-$289K	﹤0.01%	2447
2016 Q2	$3.19M	Buy	295,225 +158,730	+116%	+$1.36M	﹤0.01%	2760
2016 Q1	$905K	Sell	136,495 -191	-0.1%	-$1.74K	﹤0.01%	3288
2015 Q4	$2.47M	Buy	136,686 +4,337	+3%	+$59.7K	﹤0.01%	2924
2015 Q3	$1.46M	Buy	132,349 +54,154	+69%	+$575K	﹤0.01%	3190
2015 Q2	$1.13M	Buy	78,195 +3,862	+5%	+$52.4K	﹤0.01%	3301
2015 Q1	$870K	Buy	74,333 +13,915	+23%	+$188K	﹤0.01%	3448
2014 Q4	$1.01M	Buy	+60,418	New	+$883K	﹤0.01%	3380

Northern Trust's VTAE Position: Q4 2016 in Review

Northern Trust sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 270,149 shares — an estimated $5.65M sold.

Northern Trust first reported a position in VTAE in Q4 2014 and held it in 8 quarters. The position peaked at $5.65M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Northern Trust reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Northern Trust sold 270,149 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $5.65M.
Northern Trust first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 8 quarters.
Northern Trust's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $5.65M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Northern Trust's 13F filing for Q4 2016, filed 13 Feb 2017.